Doximity Inc (NYSE: DOCS) kicked off on Friday, down -9.59% from the previous trading day, before settling in for the closing price of $72.57. Over the past 52 weeks, DOCS has traded in a range of $40.87-$85.21.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 79.45%. While this was happening, its average annual earnings per share was recorded 6.77%. With a float of $132.50 million, this company’s outstanding shares have now reached $136.53 million.
Doximity Inc (DOCS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Doximity Inc is 29.27%, while institutional ownership is 66.48%. The most recent insider transaction that took place on Oct 10 ’25, was worth 354,200. Before that another transaction happened on Oct 01 ’25, when Company’s Director sold 2,000 for $70.01, making the entire transaction worth $140,020. This insider now owns 19,839 shares in total.
Doximity Inc (DOCS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.3 earnings per share (EPS), higher than consensus estimate (set at 0.26) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.20% during the next five years compared to 79.45% growth over the previous five years of trading.
Doximity Inc (NYSE: DOCS) Trading Performance Indicators
Take a look at Doximity Inc’s (DOCS) current performance indicators. Last quarter, stock had a quick ratio of 6.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.84. Likewise, its price to free cash flow for the trailing twelve months is 42.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.16, a number that is poised to hit 0.38 in the next quarter and is forecasted to reach 1.67 in one year’s time.
